Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 48,783 | 27,257 | 16,546 | 9,657 | 7,000 |
| Cost of Goods | 17,533 | 10,403 | 6,938 | 4,829 | 4,150 |
| Gross Profit | 31,250 | 16,854 | 9,608 | 4,828 | 2,850 |
| Operating Expenses | 24,858 | 16,292 | 11,704 | 9,291 | 7,740 |
| Operating Income | 6,925 | 965 | -1,158 | -3,634 | -4,740 |
| Interest Expense | 55 | 135 | 167 | 163 | 90 |
| Other Income | 281 | 221 | 44 | 69 | 40 |
| Pre-tax Income | 7,151 | 1,051 | -1,281 | -3,728 | -4,790 |
| Income Tax | -11,898 | N/A | N/A | N/A | 0 |
| Net Income Continuous | 19,049 | 1,051 | -1,281 | -3,728 | -3,718 |
| Net Income | $19,049 | $1,051 | $-1,281 | $-3,728 | $-4,790 |
| EPS Basic Total Ops | 10,451.33 | 574.25 | -803.95 | -2,182.15 | -3,215.75 |
| EPS Basic Continuous Ops | 10,421.44 | 605.69 | -754.09 | -2,233.37 | -2,478.67 |
| EPS Diluted Total Ops | 9,647.38 | 574.25 | -803.95 | -2,182.15 | -3,215.75 |
| EPS Diluted Continuous Ops | 9,642.44 | 565.40 | -754.09 | -2,233.37 | -2,478.67 |
| EBITDA(a) | $7,326 | $1,211 | $-993 | $-3,468 | $-4,630 |